brodalumab

Will Low Pricing for Siliq Be Enough to Help Valeant Turn Things Around?
Motley Fool
Tue, 04/25/17 - 11:10 am
Valeant Pharmaceuticals
Siliq
drug pricing
brodalumab
psoriasis
AstraZeneca
Amgen
Valeant Has 2 Catalysts Ahead
Seeking Alpha
Thu, 10/6/16 - 09:35 am
Valeant Pharmaceuticals
Vesneo
brodalumab
Earnings Preview: Is Valeant Set to Rise Based on Recent Wins?
Market Realist
Thu, 08/4/16 - 09:58 am
earnings
Valeant Pharmaceuticals
Relistor
brodalumab
Valeant gets FDA panel recommendation for psoriasis drug
Marketwatch
Tue, 07/19/16 - 10:15 pm
Valeant Pharmaceutcals
FDA
advisory panels
psoriasis
brodalumab
A Deeper Dive Into Valeant's Brodalumab Safety Issues
Seeking Alpha
Mon, 07/18/16 - 09:43 am
Valeant Pharmaceuticals
brodalumab
clinical trials
suicides
FDA review details suicides, cardio risks linked to Valeant’s $100M drug brodalumab
Endpoints
Fri, 07/15/16 - 10:27 am
FDA
Valeant Pharmaceuticals
suicide
brodalumab
psoriasis
Valeant - Baby Steps Back To Prosperity
Seeking Alpha
Thu, 07/7/16 - 09:21 am
Valeant Pharmaceuticals
brodalumab
psoriasis
AstraZeneca Transfers Valeant's European Rights To Troubled Drug
Investors.com
Fri, 07/1/16 - 10:27 am
AstraZeneca
Valeant Pharmaceuticals
brodalumab
psoriasis
The top 10 biopharma pipeline disasters of 2015
Fierce Biotech
Fri, 10/30/15 - 09:55 am
Eli Lilly
GSK
AstraZeneca
Shire
Celladon
Takeda
Merck
Roche
Verastem
evacetrapib
Breo Ellipta
brodalumab
selumetinib
SHP625
Mydicar
Alisertib
suggammadex
sembragiline
Defactinib
AstraZeneca auctions off troubled psoriasis drug to Valeant in $445M deal
Fierce Biotech
Tue, 09/1/15 - 09:55 am
AstraZeneca
Valeant Pharmaceuticals
psoriasis
brodalumab
AstraZeneca isn't giving up on brodalumab despite its links to suicide
Fierce Biotech
Fri, 07/31/15 - 03:16 pm
AstraZeneca
brodalumab
suicide
psoriasis
AstraZeneca Near Decision on Suicide-Linked Drug, CEO Says
Bloomberg
Tue, 06/2/15 - 09:09 am
AstraZeneca
Pharma CEOs
Pascal Soriot
psoriasis
brodalumab
Can AZ salvage brodalumab against next-gen psoriasis field?
Fierce Pharma Marketing
Tue, 05/26/15 - 08:07 pm
AstraZeneca
brodalumab
psoriasis
Novartis AG and Amgen Inc. Take Aim at Johnson & Johnson
Motley Fool
Mon, 12/15/14 - 08:50 am
Novartis
Amgen
JNJ
Stelara
psoriasis
brodalumab
Cosentyx
Amgen, AstraZeneca's brodalumab beats J&J's Stelara in 2nd PhIII psoriasis showdown
Fierce Biotech
Wed, 11/26/14 - 11:38 am
Amgen
AstraZeneca
brodalumab
JNJ
Stelara
psoriasis
Amgen psoriasis drug tops J&J's Stelara in Phase III study
Yahoo/Reuters
Wed, 11/12/14 - 08:32 am
Amgen
psoriasis
JNJ
brodalumab
Stelara
3 Undervalued Amgen Growth Opportunities to Watch
Motley Fool
Mon, 06/16/14 - 09:03 pm
Amgen
evolocumab
Kyprolis
brodalumab
AMG-334
Amgen psoriatic arthritis drug maintains efficacy after 1 yr -study
Yahoo/Reuters
Wed, 06/11/14 - 05:31 pm
Amgen
psoriatic arthritis
brodalumab
Amgen, AstraZeneca reports brodalumab study met primary, secondary endpoints
The Fly on the Wall
Sat, 05/10/14 - 10:48 am
Amgen
AstraZeneca
brodalumab
New class of psoriasis drugs being developed
Bloomberg
Fri, 10/4/13 - 10:14 am
psoriasis
Novartis
AstraZeneca
Amgen
Eli Lilly
Enbrel
secukinumab
brodalumab
IL-17 blockers

Pages